Heather Landau

Heather Landau

UNVERIFIED PROFILE

Are you Heather Landau?   Register this Author

Register author
Heather Landau

Heather Landau

Publications by authors named "Heather Landau"

Are you Heather Landau?   Register this Author

52Publications

1446Reads

47Profile Views

Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL Amyloidosis.

Biol Blood Marrow Transplant 2020 Jan 22;26(1):204-208. Epub 2019 Aug 22.

Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.08.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953746PMC
January 2020

Presalvage International Staging System Stage and Other Important Outcome Associations in CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Biol Blood Marrow Transplant 2020 Jan 5;26(1):58-65. Epub 2019 Sep 5.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.08.023DOI Listing
January 2020

A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study.

Leuk Lymphoma 2020 Jan 19:1-3. Epub 2020 Jan 19.

Adult BMT Service, Melvin Berlin Family Chair in Myeloma Research, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1672058DOI Listing
January 2020

Kidney transplantation in AL Amyloidosis: is it time to maximize access?

Br J Haematol 2019 Nov 15. Epub 2019 Nov 15.

Department of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16246DOI Listing
November 2019

Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry.

J Chromatogr B Analyt Technol Biomed Life Sci 2019 Sep 4;1125:121711. Epub 2019 Jul 4.

Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2019.121711DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692901PMC
September 2019

Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis.

Biol Blood Marrow Transplant 2018 09 20;24(9):1823-1827. Epub 2018 Jun 20.

Amyloidosis Center, Boston University School of Medicine, Boston, Massachusetts; Section of Hematology/Oncology, Stem Cell Transplantation Program, Boston Medical Center, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.06.018DOI Listing
September 2018

Managing multiple myeloma in elderly patients.

Leuk Lymphoma 2018 06 28;59(6):1300-1311. Epub 2017 Aug 28.

a Division of Hematologic Oncology, Department of Medicine , Memorial Sloan Kettering Cancer Center , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1365859DOI Listing
June 2018

Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance.

Biol Blood Marrow Transplant 2018 04 27;24(4):871-876. Epub 2017 Dec 27.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.12.795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6673673PMC
April 2018

Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.

J Am Soc Echocardiogr 2018 01 27;31(1):64-70. Epub 2017 Oct 27.

Department of Medicine/Cardiology Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.echo.2017.08.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985664PMC
January 2018

Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance.

Leuk Lymphoma 2017 12 9;58(12):2962-2965. Epub 2017 May 9.

a Myeloma Service, Division of Hematologic Oncology, Department of Medicine , Memorial Sloan-Kettering Cancer Center , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1312382DOI Listing
December 2017

Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation.

Leuk Lymphoma 2017 08 12;58(8):1823-1831. Epub 2017 Jan 12.

b Department of Medicine, Adult Bone Marrow Transplant Service , Memorial Sloan Kettering Cancer Center, NY Presbyterian Hospital - Weill Cornell Medical College , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1260126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554510PMC
August 2017

Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibody.

Am J Hematol 2016 12 21;91(12):E506-E508. Epub 2016 Oct 21.

Abramson Cancer Center, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132098PMC
December 2016

Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma.

Blood 2016 05 28;127(19):2355-6. Epub 2016 Mar 28.

Department of Medicine, Weill Medical College of Cornell University, New York, NY; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-01-694786DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003505PMC
May 2016

First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction.

J Clin Oncol 2016 Apr 8;34(10):1097-103. Epub 2016 Feb 8.

Morie A. Gertz, Mayo Clinic, Rochester, MN; Heather Landau, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond L. Comenzo, Tufts Medical Center; David Seldin, Boston University, Boston, MA; Brendan Weiss, University of Pennsylvania, Philadelphia, PA; Jeffrey Zonder, Karmanos Cancer Institute, Detroit, MI; Giampaolo Merlini, Fondazione Instituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy; Stefan Schönland, University of Heidelberg, Heidelberg, Germany; Jackie Walling, JW Consulting, Hillsborough; Gene G. Kinney, Martin Koller, Dale B. Schenk, and Spencer D. Guthrie, Prothena Biosciences, Inc., South San Francisco; and Michaela Liedtke, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.6530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470113PMC
April 2016

CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.

Biol Blood Marrow Transplant 2016 Feb 30;22(2):258-267. Epub 2015 Aug 30.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York; Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791150057
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2015.08.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975432PMC
February 2016

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.

J Clin Oncol 2015 Nov 14;33(32):3741-9. Epub 2015 Sep 14.

Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.4015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737858PMC
November 2015

Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium.

Adv Ther 2015 Oct 23;32(10):920-8. Epub 2015 Oct 23.

Department of Molecular Medicine, Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-015-0250-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635176PMC
October 2015

Second autologous stem cell transplant: an effective therapy for relapsed multiple myeloma.

Biol Blood Marrow Transplant 2015 Mar 18;21(3):468-72. Epub 2014 Dec 18.

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.11.677DOI Listing
March 2015

Treatment of transplant-eligible patients with multiple myeloma in 2014.

Hematol Oncol Clin North Am 2014 Oct 25;28(5):815-27. Epub 2014 Jul 25.

Adult BMT Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.06.004DOI Listing
October 2014

The checkpoint kinase inhibitor AZD7762 potentiates chemotherapy-induced apoptosis of p53-mutated multiple myeloma cells.

Mol Cancer Ther 2012 Aug 31;11(8):1781-8. Epub 2012 May 31.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-11-0949DOI Listing
August 2012

Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis.

Clin Lymphoma Myeloma Leuk 2012 Feb 18;12(1):49-58. Epub 2011 Nov 18.

Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.09.217DOI Listing
February 2012

Light chain (AL) amyloidosis: update on diagnosis and management.

J Hematol Oncol 2011 Nov 18;4:47. Epub 2011 Nov 18.

City of Hope National Cancer Center, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://jhoonline.biomedcentral.com/articles/10.1186/1756-872
Publisher Site
http://dx.doi.org/10.1186/1756-8722-4-47DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228694PMC
November 2011

Clinical manifestations and treatment of newly diagnosed acute lymphoblastic leukemia in adults.

Curr Hematol Malig Rep 2006 Sep;1(3):171-9

Memorial Sloan-Kettering Cancer Center, Leukemia Service, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-996-0005-8DOI Listing
September 2006